Mycophenolate mofetil treatment improves hypertension in patients with psoriasis and rheumatoid arthritis

Jose Herrera1, Atilio Ferrebuz, Ernesto García MacGregor

  • 1Renal Service, Hospital Universitario, Universidad del Zulia, Maracaibo, Estado Zulia, Venezuela.

Insights

Mycophenolate mofetil (MMF) significantly reduced blood pressure in hypertensive patients. This suggests that kidney inflammation and oxidative stress contribute to human hypertension, offering potential therapeutic insights.

Area of Science:

  • Nephrology
  • Immunology
  • Cardiovascular Medicine

Background:

  • Experimental models suggest kidney inflammation and oxidative stress contribute to hypertension.
  • Human studies are limited due to the unsuitability of immunosuppressive treatments for hypertension.

Purpose of the Study:

  • To investigate the role of renal immune cell infiltration and oxidative stress in human hypertension.
  • To assess the effect of mycophenolate mofetil (MMF) on blood pressure and related biomarkers in hypertensive patients.

Main Methods:

  • Studied eight patients with essential hypertension and normal renal function, prescribed MMF for other conditions.
  • Monitored blood pressure and urinary biomarkers (TNF-alpha, malondialdehyde, RANTES) during three phases: before, during, and after MMF treatment.
  • Maintained consistent diet and other treatments throughout the study.

Main Results:

  • MMF therapy significantly reduced systolic, diastolic, and mean blood pressure.
  • Urinary TNF-alpha excretion decreased during MMF treatment and increased upon discontinuation.
  • Reductions in urinary malondialdehyde and RANTES showed a positive correlation with blood pressure levels.

Conclusions:

  • MMF treatment effectively lowered blood pressure in patients with essential hypertension.
  • Findings support the hypothesis that renal immune cell infiltration and oxidative stress are implicated in human hypertension.
  • Suggests a potential therapeutic role for targeting inflammation and oxidative stress in managing hypertension.

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...